Literature DB >> 31828883

Ablation of persistent atrial fibrillation: Challenges and solutions.

Maria Terricabras1, Jonathan P Piccini2, Atul Verma1.   

Abstract

Catheter ablation is commonly used for treatment of persistent atrial fibrillation (AF). Pulmonary vein isolation (PVI) is still the cornerstone for the procedure, however, outcomes are consistently lower compared to paroxysmal AF. It is hypothesized that it could be due to lack of durable lesions or the presence of non-PV targets that remain after PVI. Numerous advances in ablation catheter technologies and mapping systems may potentially achieve lower recurrence rates in the future. Ongoing research is required to discover the best technique for persistent AF ablation. The purpose of this review is to describe the new, developing technologies that may improve the outcome of this procedure in the persistent AF population.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablation; mapping; persistent atrial fibrillation; review; technology

Mesh:

Year:  2019        PMID: 31828883     DOI: 10.1111/jce.14311

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  The hunt for extra-pulmonary vein targets in persistent atrial fibrillation.

Authors:  Dhiraj Gupta; Tolga Aksu; Andre d'Avila
Journal:  J Interv Card Electrophysiol       Date:  2022-04-06       Impact factor: 1.900

Review 2.  Pulsed Field Ablation to Treat Atrial Fibrillation: A Review of the Literature.

Authors:  Antonio Di Monaco; Nicola Vitulano; Federica Troisi; Federico Quadrini; Imma Romanazzi; Valeria Calvi; Massimo Grimaldi
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-24

3.  Ablation Therapy for Persistent Atrial Fibrillation.

Authors:  Ikechukwu Ifedili; Kristina Mouksian; David Jones; Ibrahim El Masri; Mark Heckle; John Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022

Review 4.  Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care.

Authors:  Jordi Heijman; Henry Sutanto; Harry J G M Crijns; Stanley Nattel; Natalia A Trayanova
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.